If that review does not reveal anapplicable therapeutic use exemption or departurethat caused the Atypical Finding , the Anti-DopingOrganization shall conduct the required investigation.After the investigation is completed, the Athlete andother Anti-Doping Organization s identified in Article14.1.2 shall be notified whether or not the AtypicalFinding will be brought forward as an AdverseAnalytical Finding .